The global neonatal critical care equipment market size was valued at USD 698.5 million in 2022 and is expected to witness a compound annual growth rate (CAGR) of 8.83% from 2023 to 2030. The high prevalence of neonatal jaundice, an increasing number of preterm births, and the introduction of new products for use in the Neonatal Intensive Care Units (NICU) are expected to drive the market. The World Health Organization (WHO) estimates that over 15 million infants are born prematurely each year, with about 1 million dying as a result of preterm problems. Newborn monitoring is one of the most challenging responsibilities. Developing better devices has remained significant in managing neonatal health issues. Manufacturers are making significant investments to keep up with the increasing demand for neonatal critical care equipment, particularly thermoregulation devices.
Globally, the neonatal critical care equipment market is characterized by a high rate of newborn jaundice. According to the National Center for Biotechnology Information, around 55.2% of newborns involved in the research suffered jaundice in 2018. Additionally, jaundice, or hyperbilirubinemia, occurs in roughly 60.0% of full-term infants (and 80% of preterm infants) within the first week of life, according to The Royal Children's Hospital Melbourne, Australia. As phototherapy equipment is employed as an effective treatment against neonatal jaundice, its increasing cases have a positive impact on the market.
When a baby is born before completing the 37 weeks of pregnancy, it is called a preterm birth and is admitted to the NICU. As per the March of Dimes, a U.S. non-profit organization, among the total NICU admissions more than half comprised preterm babies. According to the Centers for Disease Control and Prevention (CDC), in 2020, 1 out of every 10 infants was born prematurely. This results in increased NICU admission and a rise in the requirement for NICU facilities.
Public and private organizations are taking initiative to increase the availability of the NICUs to cope with the requirement. For instance, in September 2017, BC Children's Hospital, Vancouver, announced to launch of Teck Acute Care Centre and claimed to have North America’s first NICU to provide critical care to mothers and infants in the same room.
COVID-19 Neonatal Critical Care Equipment Market Impact: 3.6 % decrease from 2019 to 2020
Pandemic Impact |
Post COVID Outlook |
The market contracted by 3.6% year on year in 2020, compared to 2019. Initially, the lockdown imposed due to the COVID-19 pandemic has stretched medical services, disrupting maternity care across the world. |
In 2020, preterm birth affected 1 of every 10 infants born in the United States. Around 8% of births in the U.K. are preterm. That is about 60,000 babies each year, which might result in the growing demand for neonatal care devices. As a result, the market is anticipated to expand significantly during the forecast period. |
According to a report published in the BMJ Publishing Group's Fetal & Newborn Journal, the COVID-19 pandemic resulted in considerable decreases in NICU admissions and newborn resuscitations, which, in turn, negatively impacted the sales of neonatal infant care devices. |
High preference for home healthcare is expected to continue post-pandemic, creating new opportunities in the coming years. The U.S. FDA issued relaxed policies regarding noninvasive maternal and fetal monitoring devices, to ensure product availability in the market. Products allowing remote health monitoring, such as Avalon CL Fetal and Maternal Pod and Patch, were launched, which enabled infant monitoring while reducing the risk of COVID-19 infection. |
Monitoring devices are one of the important newborn care equipment in the NICU infrastructure. Hence key manufacturers are conducting research and development to launch innovative monitoring devices for use in the NICUs. For instance, in June 2019, Masimo received the U.S. Food and Drug Administration (FDA) approval for the use of its O3 Regional Oximetry on neonatal patients.
Based on type, the respiratory equipment segment dominated the market with a share of 29.7% in 2022. The growth of the segment is characterized by an increase in respiratory disorders requiring NICU admissions and the launch of new products. For instance, in September 2018, the Augmented Infant Resuscitator (AIR) was launched by Koninklijke Philips N.V to aid in the resuscitation of the asphyxiated newborn babies. The product is developed by Philips by the Consortium for Affordable Medical Technologies (CAMTech), Massachusetts.
Moreover, infants in respiratory distress are provided with ambu-bag support or oxygen therapy during transportation to a NICU facility, which does not fulfill the clinical requirements of infants, leading to patient death in many cases. Hence, in April 2019, a portable neonatal Continuous Positive Airway Pressure therapy (CPAP) system was developed by Coeo Labs in collaboration with doctors of the Consortium of Affordable Medical Technologies (CAMTech), from the U.S. and Uganda. The portable CPAP intends to provide respiratory support to neonates with Respiratory Distress Syndrome (RDS) during transportation.
On the other hand, the thermoregulation equipment segment is projected to exhibit maximum growth of 19.8% compound annual growth rate (CAGR) during the forecast period. Thermoregulation devices include newborns incubators, newborn cooling systems, radiant warmers, and others.
To keep their body temperatures steady, neonates with cold stress or hypothermia require a thermostable environment. Hypothermia is a leading cause of infant illness and mortality, according to the World Health Organization. Thus, the increased frequency of hypothermia has surged demand for thermoregulation devices.
North America dominated the market with a share of 39.3% in the year 2022 owing to a huge demand for technologically advanced products ensuring better healthcare delivery for newborns. The value-based healthcare model has led to the development of well-equipped NICU centers along with an increasing number of approvals for newborn care devices from the FDA. Furthermore, the launch and approval of advanced, next-generation devices in the U.S. & Canada are likely to boost the market.
The market in Europe is expected to grow at an 8.42% CAGR due to the increasing frequency of acquired infections among newborn babies, a growing number of hospitals, and NICUs. In addition, a sizeable patient population suffering from low birth weight and an increasing number of preterm births are poised to surge the market in Europe.
On the other hand, Asia Pacific is expected to witness remarkable growth at a 10.33% CAGR during the forecast period. This can be attributed to the high number of new births along with an increase in healthcare expenditure in the region. In addition, increasing government initiatives in developing countries such as India is favoring the growth of the market in the Asia Pacific.
The market is characterized by the increase in NICU facilities and research and development leading to the launch of new products. According to the American Hospital Association, there were around 53,096 NICUs in overall U.S. community hospitals. Also, medical service providers are adopting the use of advanced products to improve patient comfort. In May 2019, the NICU at St Peter’s Hospital announced the arrival of a transport incubator system which is used for transport while admitting the babies to a NICU and post-discharge. Some of the prominent players in the global neonatal critical care equipment market include:
Cardinal Health
Drägerwerk AG & Co. KGaA
Koninklijke Philips N.V
GE Healthcare
Medtronic
Vyaire
BD
Utah Medical Products, Inc.
Natus Medical Incorporated
Ambu A/S
Inspiration Healthcare Group plc
Report Attribute |
Details |
Market size value in 2023 |
USD 752.8 million |
Revenue forecast in 2030 |
USD 1.4 billion |
Growth Rate |
CAGR of 8.83% from 2022 to 2030 |
Base year for estimation |
2022 |
Historical data |
2016 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
Cardinal Health; Drägerwerk AG & Co. KGaA; GE Healthcare; Koninklijke Philips N.V.; Medtronic; BD; Vyaire; Utah Medical Products, Inc.; Ambu A/S; Natus Medical Incorporated; Inspiration Healthcare Group plc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2030. For this study, Grand View Research has segmented the global neonatal critical care equipment market based on type and region:
Type Outlook (Revenue, USD Million, 2016 - 2030)
Thermoregulation Equipment
Phototherapy Equipment
Monitoring Equipment
Respiratory Equipment
Others
Regional Outlook (Revenue, USD Million, 2016 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa (MEA)
South Africa
b. The global neonatal critical care equipment market size was estimated at USD 698.5 million in 2022 and is expected to reach USD 752.8 million in 2023.
b. The global neonatal critical care equipment market is expected to grow at a compound annual growth rate of 8.83% from 2023 to 2030 to reach USD 1.4 billion by 2030.
b. North America dominated the neonatal critical care equipment market with a share of around 39.3% in 2022. This is attributable to a huge demand for technologically advanced products ensuring better healthcare delivery for neonates and high adoption of the value-based healthcare model.
b. Some key players operating in the neonatal critical care equipment market are Cardinal Health, Drägerwerk AG & Co. KGaA, GE Healthcare, Koninklijke Philips N.V., Medtronic, BD, Vyaire, Utah Medical Products, Inc., Ambu A/S, Natus Medical Incorporated, Inspiration Healthcare Group plc.
b. Key factors driving the neonatal critical care equipment market growth include growth in the incidence of neonatal jaundice, an increasing number of preterm births, and the introduction of innovative equipment for use in the neonatal intensive care units (NICU).
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.